מדינה: ארמניה
שפה: אנגלית
מקור: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
ceftriaxone (ceftriaxone sodium)
Panpharma Z.I.
J01DD04
ceftriaxone (ceftriaxone sodium)
1000mg
powder for solution for injection
(25) glass vial
Prescription
Registered
2018-01-10
Company: PANPHARMA Product: Ceftonus 1 g, Powder for solution for injection Module1 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT CEFTONUS, 1 G, POWDER FOR SOLUTION FOR INJECTION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Ceftriaxone As ceftriaxone sodium .................................................................................................................................... 1 g For one vial flacon. Excipient with a known effect: sodium (83 mg per vial). For the complete list of excipients, please see section 6.1. 3. PHARMACEUTICAL FORM Powder for solution for injection or for infusion. 4.CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ceftriaxone is indicated for the treatment of the following infections in adults and children including term neonates (from birth): Bacterial Meningitis Community acquired pneumonia Hospital acquired pneumonia Acute otitis media Intra-abdominal infections Complicated urinary tract infections (including pyelonephritis) Infections of bones and joints Complicated skin and soft tissue infections Gonorrhoea Syphilis Bacterial endocarditis. Ceftriaxone may be used: For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults. For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III)) in adults and children including neonates from 15 days of age. For Pre-operative prophylaxis of surgical site infections In the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Ceftriaxone should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum (see section 4.4). Company: PANPHARMA Product: Ceftonus 1 g, Powder for solution for injection Module1 2 Consideration should be given to official guidelines on the appro קרא את המסמך השלם